Health Canada and peptides: what changed in 2026

1. 9 April 2026

   “Think twice before injecting peptides bought online”

   Health Canada’s first public advisory on peptides sold online. It named more than a dozen compounds, including BPC-157, TB-500, GHK-Cu, MOTS-c, CJC-1295, Ipamorelin and retatrutide, and warned against injecting unauthorized products.

   Read the April advisory →
2. 23 October 2026

   A dedicated peptides section on canada.ca

   Four new pages: an overview, health risks, research and clinical trials, and regulations and enforcement. They say injectable peptides are always classified as drugs, that authorized products carry an 8-digit DIN or NPN, and that a research-use label does not make a product legal to import or sell in Canada.

   Read Health Canada’s peptides pages →
3. 6 November 2026

   Bacteria found in unauthorized injectable peptides

   Health Canada tested products from an overseas manufacturer (Shanghai ERP Peptide Biotechnology) and found bacteria in them. It seized over 11,400 vials, including from two Canadian online retailers, and told people not to use or inject them. Examples listed include hCG, MOTS-C, NAD+, retatrutide, tesamorelin and tirzepatide.

   Read the November advisory →

Separate news from the United States, where in October 2026 federal health officials said they would not act against licensed pharmacies compounding six peptides on prescription, is covered in our explainer on the US decision. That policy does not apply in Canada.

• Injectable peptides are always classified as drugs, regulated under the Food and Drug Regulations, because they need stricter controls to be sterile, safe and of high quality. Source
• Authorized peptide products carry an 8-digit DIN or NPN. Unauthorized ones have not been assessed for safety, efficacy and quality. Source
• “A research use label does not make a product legal to import or sell in Canada.” Research-labelled products are subject to its requirements and enforcement. Source
• Health Canada says it monitors the market and takes action against people and businesses that sell, advertise or distribute unauthorized peptides. Source

1. Does it promise anything about your body? Dosing charts, before-and-after claims or “for weight loss” copy mean the seller is marketing a drug, not research material.
2. Can it show test results for the lot you get? Ask what was tested (purity, content) and by whom, and remember what those tests don’t cover.
3. Where does the parcel ship from? A Canadian origin scan means no border crossing; an overseas first scan tells you where it really came from.
4. Is there a real person to call? A name and a phone number you can reach before you order is a low bar, and it is worth checking.

We supply peptides for in-vitro laboratory research only. We don’t sell them for human or animal use, we publish no dosing or protocol content, and we make no health claims. Our certificates are third-party HPLC purity and measured-content results; they are for members, and they are not sterility tests. We ship from Vancouver, so there is no border crossing, and you can reach Kobi directly at (672) 339-6705.

We wrote this page because it is what people searching for peptides in Canada need to know right now, and because you should hear it from Health Canada’s own pages rather than from a seller’s summary. Read the sources below for yourself.

Questions people are asking